Abstract
Introduction: This study aims to analyze the clinical presentation and management outcomes carcinoma of vulva managed B. P. Koirala Memorial Cancer Hospital.
 Methods: A descriptive study was conducted of all carcinoma of vulva cases managed at B. P. Koirala Memorial Cancer Hospital from 1999 to 2009. The case record of all women diagnosed to have carcinoma of vulva were retrieved and socio-demographic characteristics, clinical presentations, histological type, treatment modalities and outcome were obtained and analyzed.
 Results: There were 5152 gynecological malignancies and vulvar cancer accounted for 87, giving a prevalence of 1.7%. The ages ranged from 17 to 86 years (mean of 48.6 years). Parity was 0-10. Vulva wound and pruritus were the most frequent clinical features with presentations in stage I -8%, stage II- 28%, stage III – 52 % and stage IV -12%. Squamous cell carcinoma (93%) predominated and 62% were grade I. Among the 87 cases, 32% were treated primarily with surgery, 34% primarily with concurrent chemo-radiation and 28% with combined modality. Clinical follow-up of one to five years showed that 26 (30%) cases had local recurrence and 22 (25%) died of disease.
 Conclusion: Carcinoma of the vulva is a rare gynecological malignancy in Nepal. Surgery and radiotherapy remain to be the mainstay of treatment. Delayed presentation still results in greater morbidity and mortality rates.
Highlights
This study aims to analyze the clinical presentation and management outcomes carcinoma of vulva managed B
Carcinoma of vulva is noted as a rare tumor accounting for only 0.3% of all cancers in women and 3–5% of all female genital tract malignancies, with an estimated incidence of 1–2/100,000 women.[2,3,4]
For patients who received radiotherapy to the whole pelvis including vulva, it consisted of external beam radiation therapy employing 6 MV energy using linear accelerator or irradiation by Cobalt 60 machine delivering 4,600– 5,000 cGy in daily fractions of 180 – 200 cGy with concurrent chemotherapy cisplatin 40mg/m2/wkly
Summary
This study aims to analyze the clinical presentation and management outcomes carcinoma of vulva managed B. Female genital tract cancers are very common among Nepalese women. P. Koirala Memorial Cancer Hospital, the national cancer center of Nepal reveals that cervical cancer is the commonest followed by ovarian and endometrial cancers. Cancer of vulva and vagina are less common.[1] Globally carcinoma of vulva is noted as a rare tumor accounting for only 0.3% of all cancers in women and 3–5% of all female genital tract malignancies, with an estimated incidence of 1–2/100,000 women.[2,3,4]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
